PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

Martinez FJ, White M, Guillotte-Blisnick M, Huon C, Boucharlat A, Agou F, England P, Popovici J, Hou MM, Silk SE, Barrett JR, Nielsen CM, Reimer JM, Mukherjee P, Chauhan VS, Minassian AM, Draper SJ, Chitnis CE

Open source

DOI: 10.1038/s41541-023-00796-7
Published: 2024 Jan 6
Container: NPJ vaccines
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41541-023-00796-7,
  title = {PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.},
  author = {Martinez FJ and White M and Guillotte-Blisnick M and Huon C and Boucharlat A and Agou F and England P and Popovici J and Hou MM and Silk SE and Barrett JR and Nielsen CM and Reimer JM and Mukherjee P and Chauhan VS and Minassian AM and Draper SJ and Chitnis CE},
  year = {2024},
  journal = {NPJ vaccines},
  doi = {10.1038/s41541-023-00796-7},
  url = {https://doi.org/10.1038/s41541-023-00796-7}
}

RIS

TY  - JOUR
TI  - PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
AU  - Martinez FJ
AU  - White M
AU  - Guillotte-Blisnick M
AU  - Huon C
AU  - Boucharlat A
AU  - Agou F
AU  - England P
AU  - Popovici J
AU  - Hou MM
AU  - Silk SE
AU  - Barrett JR
AU  - Nielsen CM
AU  - Reimer JM
AU  - Mukherjee P
AU  - Chauhan VS
AU  - Minassian AM
AU  - Draper SJ
AU  - Chitnis CE
PY  - 2024
JO  - NPJ vaccines
DO  - 10.1038/s41541-023-00796-7
UR  - https://doi.org/10.1038/s41541-023-00796-7
ER  -

APA

FJ, M., M, W., M, G., C, H., A, B., F, A., P, E., J, P., MM, H., SE, S., JR, B., CM, N., JM, R., P, M., VS, C., AM, M., SJ, D., & CE, C. (2024). PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.. NPJ vaccines. https://doi.org/10.1038/s41541-023-00796-7

Source records

pubmed · retrieved 2026-09-26T05:26:56.553Z